Form PREC14A - Preliminary proxy statements, contested solicitations:
SEC Accession No. 0000902664-23-002420
Filing Date
2023-03-30
Accepted
2023-03-30 17:12:30
Documents
7

Document Format Files

Seq Description Document Type Size
1 ANIKA THERAPEUTICS, INC. p23-1197prec14a.htm PREC14A 181098
2 GRAPHIC image_001.jpg GRAPHIC 4935
3 GRAPHIC image_002.jpg GRAPHIC 4930
4 GRAPHIC image_004.jpg GRAPHIC 512672
5 GRAPHIC image_005.jpg GRAPHIC 160119
6 GRAPHIC image_006.jpg GRAPHIC 35435
7 GRAPHIC image_007.jpg GRAPHIC 2544
  Complete submission text file 0000902664-23-002420.txt   1175983
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Subject) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A | Act: 34 | File No.: 001-14027 | Film No.: 23781705
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 515 MADISON AVENUE 9TH FLOOR NEW YORK NY 10022
Business Address 515 MADISON AVENUE 9TH FLOOR NEW YORK NY 10022 718-570-6018
Caligan Partners LP (Filed by) CIK: 0001727492 (see all company filings)

EIN.: 822603419 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A